Corporate News
Page 9
Sep 09, 2014
REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business
Aug 05, 2014
Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
Read about the Japanese regenerative medicine company REPROCELL Inc. and its acquisition of Reinnervate Ltd. (UK), and BioServe Inc. of MD, USA.
Feb 25, 2014
Scottish company creates first searchable database of human pharmacological responses in functional intact tissues
Biopta Ltd, the human tissue-based contract research organisation, today announced a major development in discovery research with the launch of the first catalog of assays based on human functional tissues.
Feb 05, 2014
Launch of Reinnervate Perfusion System for 3D cell culture
Read about Reinnervates announcement of the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media.
Nov 13, 2013
Biopta collaborates with Merck to investigate in vivo cardiac effects
In a recent collaboration with Merck, Biopta conducted human functional tissue experiments to investigate the mechanisms underlying two anti-arrhythmic drugs.
Nov 04, 2013
Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture
3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services.
Sep 19, 2013
Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies
Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services using Alvetex® technology.
Aug 22, 2013
Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013
Read the announcement that Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course.
Jul 31, 2013
Alvetex 3D cell culture scaffolds chosen by investigators at Massachusetts General Hospital for study of bone loss during space flight
Alvetex Scaffold system has been chosen by a group at Massachusetts General Hospital for the first ever 3D osteocytic cell culture experiments in microgravity
Apr 23, 2013
Scottish SMEs Announce Collaboration with Universities, Industry and NHS in Establishment of a £20m Stratified Medicine Scotland Innovation Centre
Today Scotland’s First Minister Alex Salmond announced the creation of a £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), at the new South Glasgow Hospitals Campus.
Jan 07, 2013
3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
Learn more about how Oncotest is integrating Alvetex Scaffold 3d cell culture technology into its cancer research screening services.
Dec 14, 2012
3D cell culture firm Reinnervate announces the release of Alvetex®Scaffold 96 well plates for high throughput 3D cell-based assays
Market leading 3D cell culture company, Reinnervate Ltd, today announced that it has launched and commenced shipments of Alvetex® Scaffold 96 well plates to customers.
Jul 09, 2012
Medicyte GmbH and Reinnervate Ltd to collaborate on development of next generation predictive 3D cell toxicity assays
Read about a new product collaboration between two market leading companies in the field of cell based assays and predictive toxicology.
Jun 27, 2012
Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd
Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd has been recognised with a top award from the Royal Society of Chemistry.
Jun 17, 2012
Reinnervate and Tecan to develop automated 3D cell culture solutions for improved cellular assays
Reinnervate Ltd and Tecan Trading AG, have signed a co-marketing agreement to develop a range of automated solutions for 3D cell culture, find out more.
Apr 30, 2012
Reinnervate Ltd and Roslin Cellab announce plans to collaborate
Reinnervate Ltd and Roslin Cellab, two leading UK companies in the fields of 3D cell culture and stem cell biology, today announced that they will join forces to develop protocols for the three dimensional growth of human Embryonic Stem Cells (hESCs).
Mar 30, 2012
Reinnervate Ltd announce Kirkstall Ltd collaboration
Reinnervate (inventors of Alvetex® Scaffold) and Kirkstall (developers of the Quasi-Vivo® system) today announced that they will collaborate to bring next generation three dimensional (3D) cell culture products to market in 2012.
Nov 16, 2011
Reinnervate and Mirus Bio announce collaboration with the launch of the new 3D Transfection System for the transfection of cells cultured in Alvetex®
Read today's announcement that Reinnervate and Mirus Bio have entered into a commercial agreement to launch a new range of 3d cell culture products.
Jun 27, 2011
Alvetex® voted one of most technologically significant new research products by R&D magazine
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of the prestigious 49th Annual R&D 100 Awards.
Dec 06, 2010
Alvetex® named in the top ten life science innovations of 2010 by The Scientist magazine
Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is proud to announce that Alvetex®, its breakthrough 3D cell culture technology, is among the winners of The Scientist magazine’s“Top 10 Life Science Innovations of 2010”.